Capital Expenditures

  • Capex of around €3.8 billion planned for 2019

We are planning total capital expenditures (additions to property, plant and equipment excluding acquisitions, IT investments, restoration obligations and right-of-use assets arising from leases) of around €3.8 billion for the BASF Group in 2019. For the period from 2019 to 2023, we have planned capital expenditures totaling €21.3 billion. The investment volume in the coming years thus exceeds that of the planning period 2018 to 2022. Projects currently being planned or underway include:

Capex: selected projects





In cooperation with Adani Group

Antwerp, Belgium


Capacity expansion: integrated ethylene oxide complex

Geismar, Louisiana


Capacity expansion: MDI plant

Ludwigshafen, Germany


Replacement: acetylene plant



Construction: production plant for vitamin A



Construction: production plant for ibuprofen

Kuantan, Malaysia


Capacity expansion: acrylic acid and butyl acrylate

Mundra, India


Investment: acrylics value chain1

Zhanjiang, China


Establishment of an integrated Verbund site

Capex by segment 2019–2023
Capex by segment, 2019–2023 (pie chart)
Capex by region 2019–2023
Capex by region, 2019–2023 (pie chart)